Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.
By Mill Chart
Last update: Apr 12, 2024
Stay updated with the stocks that are on the move in Friday's pre-market session.
Pre-market gainers
| Ticker | Change | Comment |
|---|---|---|
| MI | 3.0K% | During Friday's pre-market session, NFT LTD-A (NYSEARCA:MI) experienced a 3.0K% increase, with the stock price reaching $4.91. The stock is trading 40.23% lower than a month ago. |
| PXMD | 126.0% | During Friday's pre-market trading, PAXMEDICA INC (NASDAQ:PXMD) demonstrated strong momentum, with the stock price rising 126.0% to $0.93. A press release (PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission) was released yesterday. |
| BENF | 66.57% | BENEFICIENT - CLASS A's (NASDAQ:BENF) shares rose 66.57% to $0.12 during Friday's pre-market session. The stock is trading 83.15% lower than 3 months ago. |
| HOLOW | 50.87% | The pre-market session on Friday saw a significant rise in GOLDEN PATH ACQ -CW28's (NASDAQ:HOLOW) shares, climbing 50.87% to $0.11. In the last month the stock lost 29.62%. |
| ALLR | 43.23% | During Friday's pre-market session, ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) exhibited strong growth, with the stock price climbing 43.23% to $3.29. After yesterday's drop of -28.89%, it looks like it is bouncing back in today's pre-market session. |
| HKD | 23.66% | Exciting news for AMTD DIGITAL INC-ADR (NYSE:HKD) as their shares soared 23.66% to $3.92 during the pre-market session on Friday. The stock is trading 21.34% lower than 3 months ago. |
| TPET | 20.47% | During Friday's pre-market session, TRIO PETROLEUM CORP (NYSEARCA:TPET) experienced a 20.47% increase, with the stock price reaching $0.28. Today's pre-market session builds upon the previous day's success, as NYSEARCA:TPET continues its upward trajectory following a 26.08% gain. |
| PEPG | 16.76% | PEPGEN INC's (NASDAQ:PEPG) stock price is advancing with 16.76% to a price of $14.84. The stock is trading 85.01% higher than 3 months ago. |
| AKAN | 14.97% | The pre-market session on Friday saw a significant rise in AKANDA CORP's (NASDAQ:AKAN) shares, climbing 14.97% to $0.17. The positive trend witnessed yesterday with a 26.25% gain persists in today's pre-market, indicating sustained growth for NASDAQ:AKAN. |
| GL | 12.87% | Exciting news for GLOBE LIFE INC (NYSE:GL) as their shares soared 12.87% to $55.5 during the pre-market session on Friday. After experiencing a -53.14% loss in the previous session, NYSE:GL is showing resilience and signs of recovery in today's pre-market session. Yesterday the company had a press release: GLOBE LIFE ALERT: Bragar Eagel & Squire, P.C. is Investigating Globe Life, Inc. on Behalf of Globe Life Stockholders and Encourages Investors to Contact the Firm. |
Our premarket gainers page will show you the full list.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| MOTS | -35.72% | MOTUS GI HOLDINGS INC's (NASDAQ:MOTS) shares fell 35.72% to $0.27 during Friday's pre-market session. In the last month the share price dropped with 33.01%. |
| MGRM | -15.03% | MONOGRAM ORTHOPAEDICS INC's (NASDAQ:MGRM) stock price decreased by 15.03% to $3.46. Yesterday's significant 79.3% gain in NASDAQ:MGRM is met with a 15.03% decline in today's pre-market session, reflecting a shift in market sentiment. |
| RLYB | -14.09% | RALLYBIO CORP's (NASDAQ:RLYB) stock price is declining with 14.09% to a price of $2.56. Following yesterday's notable 82.82% increase, NASDAQ:RLYB undergoes a 14.09% decrease in today's pre-market session, suggesting a temporary pullback. Two days ago the company had a press release: Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). |
| ADIL | -12.75% | ADIAL PHARMACEUTICALS INC's (NASDAQ:ADIL) shares fell 12.75% to $2.6. After experiencing a 27.9% increase in yesterday's session, NASDAQ:ADIL is showing a reversal in today's pre-market session with a 12.75% decrease. |
| LXEH | -12.51% | LIXIANG EDUCATION HOLDIN-ADR's (NASDAQ:LXEH) stock price recorded a 12.51% decrease, falling to $0.57. Following yesterday's gain of 69.49%, NASDAQ:LXEH experiences a 12.51% decrease in today's pre-market session, indicating a pullback from the previous session's performance. |
| RENT | -10.73% | Despite yesterday's decline, RENT THE RUNWAY INC-A (NASDAQ:RENT) experienced a further 10.73% decrease in share price during Friday's pre-market session, reaching $17.3. Following an impressive 162.0% run-up in yesterday's session, NASDAQ:RENT experiences a pullback in today's pre-market session, showcasing the market's dynamic nature. Two days ago the company had a press release: Rent the Runway, Inc. Announces Fourth Quarter and Full Year 2023 Results. |
| LKCO | -10.0% | The pre-market session on Friday witnessed a 10.0% decrease in LUOKUNG TECHNOLOGY CORP's (NASDAQ:LKCO) shares, with the stock price falling to $0.5. The stock is trading 26.75% lower than a month ago. |
| MRIN | -9.57% | MARIN SOFTWARE INC's (NASDAQ:MRIN) stock price decreased by 9.57% to $0.54. In the last month the share price increased with 93.74%. |
| ELYM | -9.39% | The stock price of ELIEM THERAPEUTICS INC (NASDAQ:ELYM) is experiencing a decline of 9.39%, reaching $4.15 in today's pre-market session on Friday. Following an impressive 71.54% run-up in yesterday's session, NASDAQ:ELYM experiences a pullback in today's pre-market session, showcasing the market's dynamic nature. A press release (ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders) was released yesterday. |
| AKLI | -8.63% | AKILI INC's (NASDAQ:AKLI) shares fell 8.63% to $0.23 during Friday's pre-market session. In the last 3 months the share price dropped with 35.05%. |
To see the full list of premarket losers you can use our premarket losers page.
ALLARITY THERAPEUTICS INC
NASDAQ:ALLR (5/3/2024, 7:00:00 PM)
After market: 1.03 +0.03 (+3%)1
-0.23 (-18.7%)
ALLR News
22 hours ago - ChartmillWhich stocks are experiencing notable movement on Friday?Which stocks are experiencing notable movement on Friday?
2 days ago - ChartmillThursday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.
2 days ago - InvestorPlaceJPMorgan Just Raised Its Price Target on Carvana (CVNA) StockCarvana stock is climbing higher on Thursday after shares of CVNA got an increased price target and upgrade from JPMorgan analyst Rajat Gupta.
2 days ago - InvestorPlaceEmergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job CutsEmergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities.
2 days ago - InvestorPlaceWhy Is Allarity Therapeutics (ALLR) Stock Up 39% Today?Allarity Therapeutics stock is rising higher on Thursday as investors in ALLR celebrate the company ending a clinical trial early.
2 days ago - ChartmillGapping stocks in Thursday's sessionThe market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
2 days ago - ChartmillThursday's pre-market session: top gainers and losersGet insights into the top gainers and losers of Thursday's pre-market session.
2 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian CancerBoston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...
5 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price RequirementBoston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...
17 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
